Pharmacytimes: Condition Center: Mental Health Mental Health en-us Mon, 23 Oct 2017 09:43:19 UTC Mon, 23 Oct 2017 09:43:19 UTC 5 Psychiatry Studies Pharmacists Should Know About Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about. 3:47 AM, Wed September 20, 2017 Pharmacists Can Play Important Role in Depression Screening According to the US Preventive Services Task Force&#39;s (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries. 3:10 PM, Sun September 3, 2017 What is the National Council on Patient Information and Education? Here is the 411 on this organization, which offers programs to help consumers better understand their medications. 11:36 PM, Wed August 23, 2017 Management of Psychosis in Parkinson's Disease: Clinical Tidbits What are the best practice considerations for managing Parkinson's Psychosis? 11:26 PM, Tue May 9, 2017 Carving Out a Niche in the Treatment of Tardive Dyskinesia The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia. 1:33 AM, Wed May 3, 2017 5 Interesting Medication Case Reports - Part 3 This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice. 9:54 PM, Wed April 26, 2017 Fighting the Stigma Around Mental Illness What are you doing to stop the stigma surrounding mental illnesses? 10:46 PM, Mon February 20, 2017 The Key to Better Bipolar I Disorder Control? What can you (or your pharmacist) do to improve Bipolar I Disorder outcomes? 8:20 PM, Sun February 12, 2017 Study Notes Missed Opportunity for HIV Detection A new study, published in <em>Psychiatric Services,</em> reveals a missed opportunity for early HIV detection and treatment.&nbsp; 9:44 AM, Tue January 24, 2017 Ajanta Launches Generic Abilify in US Market Ajanta has launched&nbsp;aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States. 7:00 AM, Tue November 29, 2016 Study Shows More Than 50% of Americans Have at Least 1 Chronic Health Condition, Mental Disorder, or Substance Use Issue <p>The election has brought discussion about the complexity of the US health care system to the forefront. A new study from <em>Psychology, Health &amp; Medicine</em> reveals just how intricate the medical needs of Americans really are.</p> 11:04 AM, Tue November 8, 2016 FDA Approves sNDA for Label Changes to ADASUVE The FDA has approved the supplemental New Drug Application for label changes to ADASUVE (loxapine) inhalation powder. 7:00 AM, Mon October 24, 2016 Vraylar The FDA has approved Vraylar, an atypical antipsychotic, for the treatment of schizophrenia and the acute treatment of mixed or manic episodes associated with bipolar I disorder. 5:25 AM, Fri May 13, 2016 Ideal Adherence Interventions for Bipolar Patients Patients diagnosed with bipolar disorder are at very high risk for medication nonadherence. 12:06 AM, Fri March 18, 2016 Common Antipsychotic Linked to Compulsive Gambling There is a potential correlation between aripiprazole use and increased risk for compulsive gambling and hypersexuality. 1:16 AM, Tue January 19, 2016 Adding Anticonvulsant to Antipsychotic May Benefit Bipolar Patients Combining lamotrigine with quetiapine may improve depressive symptoms and clinical remission rates in patients with bipolar disorder. 9:46 PM, Wed January 13, 2016 10 Surprising Off-Label Uses for Prescription Medications How many of these off-label uses have you seen before? 4:01 AM, Tue January 5, 2016 Vraylar Approved for Schizophrenia, Bipolar Disorder The FDA has approved cariprazine (Vraylar) to treat schizophrenia and manic or mixed episodes associated with bipolar disorder. 8:46 AM, Fri September 18, 2015 Bipolar Depression: Which Drug Works Best? Clinicians would like to have better information about treatment options for bipolar depression, but clinical trials of any length are scarce. 10:00 PM, Mon September 14, 2015 Atypical Antipsychotic Lowers Bipolar Disorder Treatment Costs In the recent past, bipolar disorder has been classified as the most costly mental illness. 10:52 PM, Mon August 31, 2015